Stress, behavior and the heart by A. Sgoifo et al.
Accepted Manuscript
Title: STRESS, BEHAVIOR AND THE HEART
Author: Andrea Sgoifo Nicola Montano Murray Esler Viola
Vaccarino
PII: S0149-7634(16)30669-8
DOI: http://dx.doi.org/doi:10.1016/j.neubiorev.2016.11.003
Reference: NBR 2652
To appear in:
Received date: 28-10-2016
Accepted date: 3-11-2016
Please cite this article as: Sgoifo, Andrea, Montano, Nicola, Esler, Murray, Vaccarino,
Viola, STRESS, BEHAVIOR AND THE HEART.Neuroscience and Biobehavioral
Reviews http://dx.doi.org/10.1016/j.neubiorev.2016.11.003
This is a PDF ﬁle of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its ﬁnal form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
STRESS, BEHAVIOR AND THE HEART  
 
ANDREA SGOIFO1, NICOLA MONTANO2, MURRAY ESLER3 and VIOLA VACCARINO4 
 
1 - Department of Neuroscience, University of Parma, Italy 
2 - Fondazione IRCSS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy 
3 - Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct, 
Melbourne, Victoria 3004, Australia 
4 - Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, 
United States 
 
Editorial 
 
A broad spectrum of research, spanning epidemiological studies, clinical research, preclinical 
investigations and animal models, has pointed to a link between psychological factors and 
cardiovascular dysfunctional states. 
Acute and chronic life stressors, psychological alterations such as anxiety and depression, 
personality traits such as anger and hostility, reactive behavioral coping strategies, as well as the 
absence of social support have all been shown to interfere with and modulate the onset and 
progression of cardiovascular alterations. These psychological elements, in many instances, appear 
to be independent risk factors of disease, as important as traditional ones such as cholesterol 
levels, waist fat, body mass index and poor physical activity.  
Recently developed research approaches have shed light on the brain substrates, genetic and 
epigenetic factors, as well as cellular/molecular mechanisms that underlie the tight and complex 
relationship between stress, behavior and the cardiovascular system. However, despite a growing 
number of empirical investigations and accumulating clinical evidence, still several issues remain to 
be clarified about the mechanisms linking stressful events, psychological traits, behavioral coping 
and cardiovascular risk profiles. 
This special issue is a collection of 19 selected review papers that present the newest scientific 
evidence in the multidisciplinary arena intersecting stress, behavior and the cardiovascular system. 
It gathers the contribution of leading scientists from a variety of disciplines (neuroscience, 
physiology, cardiology, pharmacology, psychology, epidemiology) who share a common interest in 
the complex interactions between the mind and the heart. A deeper understanding of such 
complex relationship cannot be achieved without a multipronged effort that includes basic science, 
preclinical research on animal models and human clinical and nonclinical studies. Moreover, the 
intricate interaction between genetic and environmental factors has to take into central account a 
lifecourse approach that includes early stages of development and the effect of epigenetic 
imprinting. 
The paper by Eric Brunner focuses on the epidemiologic evidence about direct and indirect 
pathways from chronic stress to cardiovascular morbidity and mortality and underscores the fact 
that the stepwise gradient of higher cardiovascular risk with lower social status is accounted for in 
good part by social gradients in health behaviors (Brunner 2016) 
The review by Murray Esler examines the phenomenon of “triggered” heart disease, when the 
autonomic nervous system control of the heart by the brain goes awry, producing heart disease of 
sudden onset, precipitated by acute emotional upheaval, in the form of cardiac arrhythmias, 
myocardial infarction, Takotsubo cardiomyopathy and sudden death. The paper also comments on 
the evidence that chronic psychological stressors do have adverse cardiovascular consequences, 
for instance in the causal linkage of depressive illness to heart disease, and in the probable 
causation of atherosclerosis and hypertension by chronic mental stress (Esler 2016). 
Brenda Penninx’s paper examines the mechanisms through which depression’s burden of disease 
goes beyond emotional functioning and quality of life and extends to somatic health. Her paper 
reviews results from longitudinal cohort studies showing that depression, overall, increases the risk 
of cardiovascular morbidity and mortality of about 80%. According to her, the impact of major 
depressive disorder on cardiovascular health may be partly explained by mediating mechanisms 
such as unhealthy lifestyle (smoking, excessive alcohol use, physical inactivity, unhealthy diet, 
therapy non-compliance). Many biological pathways also play a role. The most relevant 
pathophysiological alterations, involving autonomic, HPA-axis, metabolic and immuno-
inflammatory dysregulations are thoroughly presented and discussed  (Penninx 2016) 
An interesting point of view concerning the psychological aspects of autonomic dysfunction and 
cardiovascular risk is that presented by Jos Brosschot and colleagues. These authors refer to the 
generalized unsafety theory of stress, which focusses on safety instead of threat and includes risk 
factors that have hitherto not been attributed to stress (Brosschot et al. 2016) 
The paper by Viola Vaccarino and Douglas Bremner discusses important gender differences in both 
the frequency of psychosocial risk factors and their relationship with the risk of coronary heart 
disease. The authors provide evidence and comment on the fact that women have double the rates 
of stress-related psychiatric disorders, including PTSD and depression, compared to men, that 
these disorders are clearly associated with cardiovascular risk in women, and suggest that future 
studies should examine women in earlier developmental epochs in order to better understand 
mechanisms of disease and develop tailored intervention and prevention strategies. In particular, 
they suggest that psychosocial interventions, specifically designed to address women’s stressors, 
could be the most helpful approach in the prevention and treatment of cardiovascular dysfunction 
in women (Vaccarino & Bremner 2016). 
Walker and colleagues discuss the importance of identifying appropriate biomarkers of resilience 
to psychological stressors, thus overcoming the bias represented by subjective reports. The authors 
provide a summary of the major concepts in the field of resilience, followed by a detailed critical 
review of the literature around possible physiological, neurochemical and immune markers. They 
conclude that in future experimental protocols, putative biological markers of resilience should be 
assessed both in baseline conditions and during controlled, laboratory stress challenges (Walker et 
al. 2016). 
Sleep deprivation has become a relevant health problem in modern societies. Among its broad-
ranging effects, sleep deprivation is capable of inducing neural autonomic control changes, 
increased oxidative stress, altered inflammatory and coagulatory responses and accelerated 
atherosclerosis. All these mechanisms link sleep deprivation and cardiovascular and metabolic 
disorders. Eleonora Tobaldini and colleagues provide an up-to-date review on this important topic 
(Tobaldini et al. 2016). 
Given the intrinsic connection between the brain and the heart, a recent body of research also 
emerged with the aim of influencing cardiovascular system functioning by non-invasive brain 
stimulation (NIBS) methods such as repetitive transcranial magnetic stimulation and transcranial 
direct current stimulation. Despite the therapeutic implications of cardiovascular activity 
modulation, such effects of NIBS have not yet been systematically reviewed. The aim of the work 
by Elena Makovac and colleagues was to meta-analyze studies on NIBS effects on blood pressure, 
heart rate and heart rate variability. Their results show that NIBS does indeed affect cardiovascular 
and autonomic nervous system activity, confirming a potential pathogenic brain-heart pathway to 
cardiovascular disease (Makovac et al. 2016). 
The role of epigenetic mechanisms in the link between behavior and cardiovascular dysfunction is 
nicely exemplified in the paper by Khan and colleagues, where a specific condition (postural 
tachycardia syndrome, POTS) is analyzed. They focus their attention on the gene that encodes for 
the norephrine transporter (SLC6A2) and highlight the potential therapeutic application of 
strategies that target the epigenetic mechanisms implicated in the regulation of SLC6A2 expression 
in POTS (Khan et al. 2016). 
Life stress has been associated with accelerated cellular aging and increased risk for developing 
aging-related diseases, including cardiovascual disturbances. However, the underlying molecular 
mechanisms remain rather elusive. A highly relevant process that may underlie this association is 
epigenetic regulation. In their review, Gassen and colleagues build upon existing evidence to 
propose a model whereby exposure to life stress, in part via its effects on the hypothalamic-
pituitary axis and the glucocorticoid signaling system, may alter the epigenetic landscape across 
the lifespan and, consequently, influence genomic regulation and function in ways that are 
conducive to the development of aging-related diseases (Gassen et al. 2016).  
Moving to preclinical studies involving animal models, this special issue includes a nice review 
paper by Myers and colleagues, where several brainstem nuclei are considered, which engage in 
autonomic control and therefore influence cardiovascular stress responsivity. In particular, this 
review focuses on the prominent brainstem monosynaptic inputs to the paraventricular 
hypothalamic nucleus, involving the periaqueductal gray, raphe nuclei, parabrachial nuclei, locus 
coeruleus, and nucleus of the solitary tract. Collectively, the study of these brain circuits in rodents 
represents an important avenue for delineating the complex interactions between stress and 
health (Myers et al. 2016). 
Orexin, the arousal peptide, is the main character of Carrive’s report. This neuropeptide originates 
from neurons located in an area of the dorsal hypothalamus well known for integrating defense 
responses and their cardiovascular component. Orexin neurons project to many regions in the 
brain, including those involved in cardiovascular control, as far down as sympathetic preganglionic 
neurons in the spinal cord. The present paper examines the link between orexin, stress and 
hypertension in rats, and maintains that orexin upregulation could be a factor in the development 
of essential hypertension, while orexin receptor antagonism has anti-hypertensive effects that 
could be of clinical use (Carrive 2016). 
The review by Wood and Valentino moves the focus to norepinephrine and the locus coeruleus-
norepinephrine system as an important contributor to stress-induced cardiovascular disease. 
Interestingly, the authors examine the role of individual differences in behavioral coping strategies 
on cardiovascular vulnerability induced by social stress in rats. In fact, the establishment of 
different coping strategies and cardiovascular vulnerability during repeated social stress has 
recently been shown to parallel a unique plasticity in locus coeruleus afferent regulation, resulting 
in either excitatory or inhibitory inputs. This contrasting regulation of the LC would translate to 
differences in cardiovascular function modulation and may serve as the basis for individual 
differences in the cardiopathological consequences of social stress. The advances described 
suggest new directions for developing treatments and/or strategies for decreasing stress-induced 
cardiovascular vulnerability (Wood & Valentino 2016) 
Expanding the issue of individual differences in stress coping for health and disease, De Boer and 
colleagues underscore the importance of understanding the neural embedding of coping style 
variation. This review outlines individual differences in trait-aggressiveness as an adaptive 
component of the natural sociobiology of rats and mice, and highlights that these reflect the 
general style of coping that varies from proactive (aggressive) to reactive (docile). The authors 
propose that this qualitative coping style can be disentangled into multiple quantitative behavioral 
domains, e.g., flexibility/impulse control, emotional reactivity and harm avoidance/reward 
processing, each encoded into selective neural circuitries. They also suggest that, since functioning 
of all these brain circuitries rely on fine-tuned serotonin signaling, autoinhibitory control 
mechanisms of serotonergic neuron (re)activity are crucial in orchestrating general coping style. 
Thus, it is reasonable to believe that by untangling the precise neuromolecular mechanisms of 
different coping styles, we could provide a road map for developing better therapeutic strategies 
of stress-related diseases (De Boer et al. 2016) 
Serotonin plays a specific modulatory role in cardiovascular stress responsivity, due to its well- 
known central control of the autonomic nervous system (ANS). The nucleus tractus solitarii (NTS) 
in the medulla is an area of viscerosomatic integration innervated by both central and peripheral 
serotonergic fibers. In particular, the NTS is the central zone with the highest density of serotonin 
3 (5-HT3) receptors. In this review by Sevoz-Couche and Brouillard, evidence is presented that 5-
HT3 receptors in the NTS of rats play a key role in one of the crucial homeostatic responses to 
acute and chronic stressors: the inhibitory modulation of the parasympathetic component of the 
ANS. The possible functional interactions of 5-HT3 receptors with GABAA and NK1 receptors in the 
NTS are also discussed (Sevoz-Couche and Brouillard 2016) 
The paper by Shively and colleagues also deals with serotonin, namely on the effects of serotonin 
re-uptake inhibitors (drugs which are widely prescribed for a number of disorders in addition to 
depression) on primate cardiovascular disease, behavior, and neuroanatomy. In particular, this 
paper focuses on the multisystem effects of sertraline treatment on adult female cynomolgous 
monkeys, a primate species shown to be a useful model for both depression and coronary and 
carotid artery atherosclerosis. Sertraline does not seem to have effects on depressive behavior, but 
it is shown to reduce anxious behavior, increase affiliation, reduce aggression, change serotonin 
neurotransmission and volumes of neural areas critical to mood disorders, and exacerbate 
coronary and carotid atherosclerosis. According to the authors, these data suggest that a 
conservative approach to prescribing SSRIs for cardiovascular or other disorders for long periods 
should be explored (Shively et al. 2016). 
The endocannabinoid system has also been implicated in the regulation of stress, emotional 
behavior and cardiovascular function. Preclinical findings indicate that the endocannabinoid 
anandamide modulates physiological and behavioral stress responses and may also protect the 
heart from arrhythmias. Moreover, recent experimental studies suggest that pharmacological 
enhancement of anandamide signaling via inhibition of its degrading enzyme fatty acid amide 
hydrolase (FAAH) exerts anxiolytic- and antidepressive-like effects and improves cardiac autonomic 
function and the electrical stability of the myocardium in rodent models that reproduce aspects of 
human psychological/cardiac comorbidity. In the review by Carnevali et al., the authors summarize 
and discuss such experimental findings, which might guide future preclinical studies towards a 
systematic evaluation of the therapeutic potential of pharmacological approaches that target FAAH 
activity for the treatment of the comorbidity between psychological disorders and cardiac disease 
(Carnevali et al. 2016). 
The last two papers composing this special issue deal with two crucial ontogenetic phases, namely 
childhood and adolescence. Emerging epidemiological data strongly support that stress 
experiences during childhood and adolescence represent an independent risk factor for 
cardiovascular disease in adulthood. Experimental animal models of chronic behavioral stress 
during early postnatal life (specifically maternal separation) and adolescence provide a suitable 
tool to elucidate potential underlying biological substrates. The reviews by Murphy and colleagues 
and by Crestani highlight current putative molecular mechanisms based on evidence from rodents 
and support the prospective value of further investigations, which could help identify appropriate 
therapies to mitigate the long-lasting cardiovascular consequences of adverse emotional situations 
that occur before adulthood (Murphy et al. 2016; Crestani 2016) 
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